,,ii  #aai? ,,congress  #b;d ,session   
,s4 #ecaf  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,augu/ #f1 #bjbf,mr4   
,ricketts 7= himself & ,ms4 ,slotk97    
introduc$ ! foll[+ bill2 :i* 0 read     
twice & ref]r$ to ! ,committee on       
,bank+1 ,h\s+1 & ,urban ,affairs  ,a    
,,bill  ,to am5d title ,,viii ( !       
,def5se ,production ,act ( #aiej to     
include biote*nology 9 ! def9itions (   
prohibit$ te*nology & notifiable        
te*nology1 & = o!r purposes4  #a4 ,%ort 
title  ,?is ,act may be cit$ z ! ,biote*
 ,inve/m5t ,national ,security ,act (   
#bjbf or ! ,,b9sa ,act4  #b4 ,f9d+s2    
s5se ( ,congress  7a7 ,f9d+s ,congress  
f9ds ! foll[+3 7#a7 ,! ,p's ,republic ( 
,*9a has pursu$ a delib]ate1            
/ate-direct$ /rategy to dom9ate global  
biote*nology1 includ+ ph>maceutical     
developm5t1 biologics manufactur+1 &    
cl9ical rese>* & developm5t             
capabilities4  7#b7 ,unit$ ,/ates       
capital fl[+ to ,*9ese biote*nology     
companies ?r\gh lic5s+ agreem5ts1 jo9t  

v5tures1 & equity inve/m5ts is accel]at+
 ! acquisition by ! ,p's ,republic (    
,*9a ( ph>maceutical intellectual       
prop]ty & cl9ical developm5t            
capabilities 9 a mann] t creates        
/rategic dep5d5cy risks = ! ,unit$      
,/ates4  7#c7 ,cross-bord] out-lic5s+   
transactions betwe5 ,unit$ ,/ates &     
,european ph>maceutical companies &     
,*9ese biote*nology firms total$        
approximately #acf1jjj1jjj1jjj 9 #bjbe1 
repres5t+ a rapid & accel]at+ transf] ( 
ph>maceutical innovation capacity to    
entities subject to ! direction &       
control ( ! ,p's ,republic ( ,*9a4  7#d7
 ,biote*nology1 includ+ ph>maceutical   
developm5t & biologics manufactur+1 has 
civil-milit>y dual-use applications &   
pres5ts /rategic dep5d5cy risks = !     
,unit$ ,/ates comp>able to ^? pres5t$ by
 semiconductors1 artificial intellig5ce1
 & o!r te*nologies already cov]$ by     
title ,,viii ( ! ,def5se ,production    
,act ( #aiej 7#ej ,u4,s4,c4 #deha et    
seq474  7#e7 ,section #hea ( ! ,national

 ,def5se ,au?orization ,act = ,fiscal   
,ye> #bjbf 7,public ,law #aai-fj2 #da   
,u4,s4,c4 #cija note prec47 7commonly   
ref]r$ to z ! ,,biosecure ,act71        
recogniz$ t biote*nology is bo? a       
national security asset & a /rategic    
vuln]ability1 & t ! ,p's ,republic (    
,*9a seeks to dom9ate biote*nology z an 
indu/ry ( ! future4  7b7 ,s5se (        
,congress ,x is ! s5se ( ,congress t    
consi/5t application ( outb\nd inve/m5t 
scre5+ to biote*nology is necess>y to   
prev5t ,unit$ ,/ates capital &          
intellectual prop]ty f accel]at+ !      
dom9ance by ! ,p's ,republic ( ,*9a ( ! 
ph>maceutical innovation supply *a9 9 a 
mann] t w create long-t]m /rategic      
dep5d5cy risks analog\s to ^? ! ,unit$  
,/ates n[ faces ) respect to r>e e>?    
elem5ts & semiconductors4  #c4          
,inclusion ( biote*nology & lic5s+ (    
te*nologies 9 prohibit$ & notifiable    
transactions ,section #hji ( ! ,def5se  
,production ,act ( #aiej 7#ej ,u4,s4,c4 
#dehi7 is am5d$-- 7#a7 9 p>agraph       

7#d77;,a7-- 7,a7 9 clause 7vii71 by     
/rik+ 2 or & ins]t+ a semicolon2  7,b7  
by r$esignat+ clause 7viii7 z clause    
7ix72 &  7,c7 by ins]t+ aft] clause     
7viii7 ! foll[+3  7viii7 lic5s+ ( a     
prohibit$ te*nology f a cov]$ =eign     
p]son2 or  2  7#b7 9 p>agraph 7#g77;,a71
 by add+ at ! end ! foll[+3  7vi7       
,biote*nology1 mean+ ! rese>*1          
developm5t1 manufactur+1 or             
comm]cialization (-- 7,i7 ph>maceutical 
products 7:i* has ! mean+ giv5 ! t]m    
drug 9 section #bja7;g77#a7 ( ! ,f$]al  
,food1 ,drug1 & ,cosmetic ,act 7#ba     
,u4,s4,c4 #cba7;g77#a7772  7,,ii7       
biological products 7z def9$ 9 section  
#cea7;i7 ( ! ,public ,heal? ,s]vice ,act
 7#db ,u4,s4,c4 #bfb7;i7772 &  7,,iii7  
!rapeutic comp\nds1 includ+ drug        
discov]y plat=ms1 cl9ical rese>* &      
developm5t capabilities1 biologics      
manufactur+1 & intellectual prop]ty &   
"k-h[ relat+ to !rapeutic comp\nds4  2 &
  7#c7 9 p>agraph 7#aj77;,a71 by add+ at
 ! end ! foll[+3  7vi7 ,biote*nology1   

mean+ ! rese>*1 developm5t1 manufactur+1
 or comm]cialization (-- 7,i7           
ph>maceutical products 7:i* has ! mean+ 
giv5 ! t]m drug 9 section #bja7;g77#a7 (
 ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act
 7#ba ,u4,s4,c4 #cba7;g77#a7772  7,,ii7 
biological products 7z def9$ 9 section  
#cea7;i7 ( ! ,public ,heal? ,s]vice ,act
 7#db ,u4,s4,c4 #bfb7;i7772 &  7,,iii7  
!rapeutic comp\nds1 includ+ drug        
discov]y plat=ms1 cl9ical rese>* &      
developm5t capabilities1 biologics      
manufactur+1 & intellectual prop]ty &   
"k-h[ relat+ to !rapeutic comp\nds4  4  
#d4 ,rulemak+  7a7 ,9 g5]al ,! ,secret>y
 ( ! ,treasury %all1 n lat] ?an #a ye>  
aft] ! date ( ! enactm5t ( ?is ,act1    
issue a rule to fur!r def9e ! p>amet]s (
 ! area ( biote*nology1 z us$ 9         
p>agraphs 7#g77;,a7 & 7#aj77;,a7 (      
section #hji ( ! ,def5se ,production    
,act ( #aiej1 z am5d$ by section #c4    
7b7 ,requirem5ts ,:5 def9+ ! p>amet]s ( 
! area ( biote*nology pursuant to       
subsection 7a71 ! ,secret>y ( !         

,treasury %all-- 7#a7 consult ) !       
,secret>y ( ,heal? & ,human ,s]vices1 ! 
,secret>y ( ,def5se1 & ! ,director (    
,national ,intellig5ce2  7#b7 give      
p>ticul> consid]ation to transactions   
involv+ ! lic5s+ ( intellectual prop]ty1
 drug discov]y plat=ms1 cl9ical rese>* &
 developm5t capabilities1 & biologics   
manufactur+ "k-h[ to cov]$ =eign p]sons 
7z def9$ 9 section #hji ( ! ,def5se     
,production ,act ( #aiej72  7#c7 give   
p>ticul> consid]ation to lic5s+         
transactions1 jo9t v5tures1 & equity    
inve/m5ts involv+ drug discov]y plat=ms1
 cl9ical developm5t capabilities1 &     
biologics manufactur+ z priority        
categories = bo? ! prohibit$ &          
notifiable te*nology ti]s )9 !          
biote*nology sector2  7#d7 consid] !    
degree to :i* a transaction w\ld transf]
 ph>maceutical innovation capacity1     
cl9ical developm5t capabilities1 or     
manufactur+ "k-h[ to entities subject to
 ! direction or control ( ! ,p's        
,republic ( ,*9a2 &  7#e7 n def9e !     

biote*nology sector 9 a mann] t includes
 or c\ld be con/ru$ to include          
agricultural biote*nology1 indu/rial    
f]m5tation unrelat$ to ph>maceutical or 
!rapeutic production1 or basic academic 
rese>* ) no direct ph>maceutical or     
!rapeutic application4  #e4 ,report     
requir$  7a7 ,9 g5]al ,n lat] ?an #fj   
days aft] ! date ( ! enactm5t ( ?is     
,act1 ! ,secret>y ( ,def5se %all submit 
to ! appropriate congressional          
committees a report assess+ :e!r fl[s ( 
! ,unit$ ,/ates capital into !          
biote*nology sector ( ! ,p's ,republic (
 ,*9a1 includ+ ?r\gh lic5s+ transactions
 ) ,*9ese biote*nology firms1 negatively
 affect ! ,unit$ ,/ates national        
security & milit>y read9ess4  7b7 ,=m ,!
 report requir$ by subsection 7a7 %all  
be submitt$ 9 unclassifi$ =m b may      
include a classifi$ annex4  7c7         
,appropriate congressional committees   
def9$ ,9 ?is section1 ! t]m appropriate 
congressional committees means-- 7#a7 ! 
,committee on ,arm$ ,s]vices ( ! ,h\se (

 ,repres5tatives2  7#b7 ! ,committee on 
,f9ancial ,s]vices ( ! ,h\se (          
,repres5tatives2  7#c7 ! ,p]man5t       
,select ,committee on ,intellig5ce ( !  
,h\se ( ,repres5tatives2  7#d7 ! ,select
 ,committee on ! ,/rategic ,competition 
betwe5 ! ,unit$ ,/ates & ! ,*9ese       
,communi/ ,p>ty ( ! ,h\se (             
,repres5tatives2  7#e7 ! ,committee on  
,arm$ ,s]vices ( ! ,s5ate2  7#f7 !      
,committee on ,bank+1 ,h\s+1 & ,urban   
,affairs ( ! ,s5ate2 &  7#g7 ! ,select  
,committee on ,intellig5ce ( ! ,s5ate4